Cristina Perez
Pamplona, NC 00489, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma.
Journal: Blood cancer discovery
Published: October 01, 2024
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance.
Journal: Nature communications
Published: November 25, 2022
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 17, 2022
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.
Journal: Nature medicine
Published: February 02, 2022
Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma.
Journal: Science advances
Published: January 19, 2022
A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 22, 2021
The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 22, 2018
B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies.
Journal: Haematologica
Published: February 06, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026